Gossamer Bio, Inc. (GOSS) vs Hyperion DeFi, Inc. (HYPD)

Gossamer Bio, Inc. and Hyperion DeFi, Inc. are both Biotechnology companies. Gossamer Bio, Inc. and Hyperion DeFi, Inc. are of similar size ($66.8M and $64.8M). Hyperion DeFi, Inc. grew revenue faster over the last twelve months: 1,990.6% against 32.4%. Gossamer Bio, Inc. has the higher net margin (−235.0% vs −1,224.5%) and the lower return on invested capital (0.00% vs 2.73%). Across the 16 metrics below, Gossamer Bio, Inc. leads on 8 and Hyperion DeFi, Inc. on 8.

Valuation

Metric GOSS HYPD Biotechnology median
P/E n/m n/m 7.88
P/S 0.82 40.88 11.47
P/B n/m 0.56 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 11.46 0.74
EV/Sales 4.16 40.02 10.73
Earnings yield (416.82%) (153.22%) (28.84%)
Free cash flow yield (371.79%) (134.77%) (23.03%)

Profitability

Metric GOSS HYPD Biotechnology median
Gross margin 100.00% 78.35% 65.16%
Operating margin (311.70%) 314.32% 0.00%
Net margin (235.00%) (1,224.53%) 0.00%
Free cash flow margin (305.19%) (5,509.35%) 0.00%
Return on equity 178.72% (24.63%) (57.72%)
Return on assets (78.81%) (20.32%) (49.22%)
Return on invested capital 0.00% 2.73% 0.00%

Growth

Metric GOSS HYPD Biotechnology median
Revenue growth (TTM) 32.43% 1,990.60% 5.64%
EPS growth (last fiscal year) (200.00%) 84.28% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GOSS HYPD Biotechnology median
Debt to equity (0.38) 0.08 0.00
Current ratio 0.53 2.34 4.73
Net debt to EBITDA (0.35) (0.03) 0.96

Dividend

Metric GOSS HYPD Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric GOSS HYPD Biotechnology median
Market cap 66.79m 64.80m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack